BackLiveOne- 9% PRF PERPETUAL USD 25 - Ser A Overview

LiveOne- 9% PRF PERPETUAL USD 25 - Ser A EBIT

Track LiveOne- 9% PRF PERPETUAL USD 25 - Ser A's EBIT ($-13M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$2.46M
22.63% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$12.85M
28.05% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

LiveOne- 9% PRF PERPETUAL USD 25 - Ser A (LVOPP) FAQ

As of the most recent data (June 2026), LVOPP shows a EBIT of $-13M. That compares with $-18M in the prior-year period — up 28.0% year over year. That is below the Technology sector average of $14T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LVOPP's EBIT is now $-13M (was $-18M) — a 28.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether LiveOne- 9% PRF PERPETUAL USD 25 - Ser A is outperforming or lagging.

The Technology sector average EBIT is about $14T. LiveOne- 9% PRF PERPETUAL USD 25 - Ser A is at $-13M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how LVOPP stacks up against individual peers as well.

Tracking LVOPP's ebit over time shows whether LiveOne- 9% PRF PERPETUAL USD 25 - Ser A is scaling, shrinking, or reshaping that part of the business. The current reading is $-13M That compares with $-18M in the prior-year period — up 28.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has LiveOne- 9% PRF PERPETUAL USD 25 - Ser A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-13M) with ownership activity and broader fundamentals.